Updates in isolated RBD

Isolated RBD (iRBD) has been established as REM sleep behavior disorder without an associated neurodegenerative condition. However, RBD is commonly…

Date: 11th May 2022

Insight into the pathogenesis of pediatric-onset MOGAD

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an inflammatory disorder mainly affecting the optic nerve, spinal cord, and brain. This…

Date: 11th May 2022

Updates in isolated RBD

Isolated RBD (iRBD) has been established as REM sleep behavior disorder without an associated neurodegenerative condition. However, RBD is commonly…

Date: 11th May 2022

Insight into the pathogenesis of pediatric-onset MOGAD

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is an inflammatory disorder mainly affecting the optic nerve, spinal cord, and brain. This…

Date: 11th May 2022

Optimizing clinical trial design for improved outcomes in multiple sclerosis

Measuring the efficacy of treatments for multiple sclerosis (MS) is challenging, due to the heterogeneity of disease presentation and the…

Date: 19th April 2022

Clinical trials in neuromuscular disorders: ALS, MG & SMA

Over the past few years, a number of novel treatments for neuromuscular disorders were approved and are now available to…

Date: 21st February 2022

Subtyping in Parkinson’s disease

It is well recognized that Parkinson’s disease (PD) can present with a broad spectrum of motor and non-motor symptoms, and…

Date: 2nd February 2022

Advances in stroke rehabilitation and recovery

Stroke is a leading cause of disability worldwide. Despite considerable improvements in acute stroke treatment, most patients are left with…

Date: 2nd February 2022